{"id":9137,"date":"2026-04-21T19:00:00","date_gmt":"2026-04-21T12:00:00","guid":{"rendered":"https:\/\/www.globenewswire.com\/news-release\/2026\/04\/21\/3277821\/0\/en\/Spur-Therapeutics-To-Present-New-Clinical-Data-on-FLT201-for-Gaucher-Disease-during-the-IWGGD-2026-Symposium.html3277821"},"modified":"2026-04-21T19:02:16","modified_gmt":"2026-04-21T12:02:16","slug":"spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium","status":"publish","type":"post","link":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","title":{"rendered":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium"},"content":{"rendered":"\n

LONDON, April 21, 2026 (GLOBE NEWSWIRE) — Spur Therapeutics<\/a> today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD) 2026 Symposium, May 3-6, 2026 in Trieste, Italy.<\/p>\n

Presentation details:<\/p>\n

Oral presentation:<\/strong><\/p>\n

Title:<\/strong> Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and GALILEO-2
Session 7: <\/strong>Therapies in Gaucher Disease (also available as a poster)<\/em>
Date & Time: <\/strong>Wednesday May 6, 09:45 – 10:00
Presenter: <\/strong>Ida Schwartz, MD, PhD, Hospital de Clinicas de Porto Alegre, Brazil<\/p>\n

Poster presentations:<\/strong><\/p>\n

Title: <\/strong>Trial in Progress: GALILEO-3, a Phase 3 Registrational Trial of avigbagene parvec (FLT201) Gene Therapy Candidate in Patients with Gaucher Disease type 1
Presenter:<\/strong> Reena Sharma, MD, Salford Royal Hospital, UK<\/p>\n

Title: <\/strong>Impact of avigbagene parvec (FLT201) on markers of bone health in adults with Gaucher disease type 1
Presenter:<\/strong> Pilar Giraldo, MD, PhD, Hospital Universitario Quironsalud, Zaragoza, Spain<\/p>\n

For more details on the symposium, please visit the IWGGD Symposium website<\/a>.<\/p>\n

About Spur Therapeutics<\/strong> 
Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions. By optimizing every component of its product candidates, Spur aims to unlock the true potential of gene therapy to realize outsized clinical results. Spur is advancing a breakthrough gene therapy candidate for Gaucher disease and disease and a preclinical gene therapy candidate for Parkinson\u2019s disease. Expanding our impact, and advancing the practice of genetic medicine. <\/p>\n

Toward life-changing therapies, and brighter futures. Toward More™ <\/p>\n

For more information, visit\u202fwww.spurtherapeutics.com<\/a>\u202for connect with Spur on\u202fLinkedIn<\/a>. <\/p>\n

Contact<\/strong> 
media@spurtherapeutics.com<\/a> <\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

LONDON, April 21, 2026 (GLOBE NEWSWIRE) — Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: Oral presentation: Title: Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and…<\/p>\n","protected":false},"author":1,"featured_media":9138,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[75,1406],"tags":[],"class_list":["post-9137","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-globenewswire"],"yoast_head":"\nSpur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium<\/title>\n<meta name=\"description\" content=\"LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: Oral presentation: Title: Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium\" \/>\n<meta property=\"og:description\" content=\"LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: Oral presentation: Title: Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Crypto Insider\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/yourcryptoinsider\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-21T12:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T12:02:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/media\/Yjk5Y2U5ODctYmEyNC00ODNlLTgzNmItYzJjODE4ZjM3N2Q1LTEyNzQ1MDEtMjAyNi0wNC0yMS1lbg==\/tiny\/Spur-Therapeutics.png\" \/>\n<meta name=\"author\" content=\"Crypto Insider\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Crypto Insider\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/\"},\"author\":{\"name\":\"Crypto Insider\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\"},\"headline\":\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium\",\"datePublished\":\"2026-04-21T12:00:00+00:00\",\"dateModified\":\"2026-04-21T12:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/\"},\"wordCount\":303,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif\",\"articleSection\":[\"Business\",\"GlobeNewswire\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/\",\"name\":\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium - Crypto Insider\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif\",\"datePublished\":\"2026-04-21T12:00:00+00:00\",\"dateModified\":\"2026-04-21T12:02:16+00:00\",\"description\":\"Crypto and Blockchain News\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif\",\"width\":1,\"height\":1},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Business\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/business\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"name\":\"Crypto Insider\",\"description\":\"Crypto and Blockchain News\",\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\",\"name\":\"Crypto Insider\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"width\":2048,\"height\":2048,\"caption\":\"Crypto Insider\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/yourcryptoinsider\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/vietnaminsider\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\",\"name\":\"Crypto Insider\",\"description\":\"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain\",\"sameAs\":[\"https:\\\/\\\/cryptoinsider.asia\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium","description":"LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: Oral presentation: Title: Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: Oral presentation: Title: Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and...","og_locale":"vi_VN","og_type":"article","og_title":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium","og_description":"LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: Oral presentation: Title: Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and...","og_url":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","og_site_name":"Crypto Insider","article_publisher":"https:\/\/www.facebook.com\/yourcryptoinsider","article_published_time":"2026-04-21T12:00:00+00:00","article_modified_time":"2026-04-21T12:02:16+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/media\/Yjk5Y2U5ODctYmEyNC00ODNlLTgzNmItYzJjODE4ZjM3N2Q1LTEyNzQ1MDEtMjAyNi0wNC0yMS1lbg==\/tiny\/Spur-Therapeutics.png","type":"","width":"","height":""}],"author":"Crypto Insider","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Crypto Insider","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"1 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#article","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"},"author":{"name":"Crypto Insider","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6"},"headline":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium","datePublished":"2026-04-21T12:00:00+00:00","dateModified":"2026-04-21T12:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"},"wordCount":303,"commentCount":0,"publisher":{"@id":"https:\/\/cryptoinsider.asia\/#organization"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/04\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif","articleSection":["Business","GlobeNewswire"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","url":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","name":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium - Crypto Insider","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#primaryimage"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/04\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif","datePublished":"2026-04-21T12:00:00+00:00","dateModified":"2026-04-21T12:02:16+00:00","description":"Crypto and Blockchain News","breadcrumb":{"@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#primaryimage","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/04\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/04\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif","width":1,"height":1},{"@type":"BreadcrumbList","@id":"https:\/\/cryptoinsider.asia\/vi\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cryptoinsider.asia\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/cryptoinsider.asia\/category\/news\/"},{"@type":"ListItem","position":3,"name":"Business","item":"https:\/\/cryptoinsider.asia\/category\/business\/"},{"@type":"ListItem","position":4,"name":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium"}]},{"@type":"WebSite","@id":"https:\/\/cryptoinsider.asia\/vi\/#website","url":"https:\/\/cryptoinsider.asia\/vi\/","name":"Crypto Insider","description":"Crypto and Blockchain News","publisher":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cryptoinsider.asia\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/cryptoinsider.asia\/vi\/#organization","name":"Crypto Insider","url":"https:\/\/cryptoinsider.asia\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","width":2048,"height":2048,"caption":"Crypto Insider"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/yourcryptoinsider","https:\/\/www.linkedin.com\/company\/vietnaminsider"]},{"@type":"Person","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6","name":"Crypto Insider","description":"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain","sameAs":["https:\/\/cryptoinsider.asia"]}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/04\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium.gif","jetpack-related-posts":[],"jetpack_likes_enabled":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/9137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/comments?post=9137"}],"version-history":[{"count":0,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/9137\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media\/9138"}],"wp:attachment":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media?parent=9137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/categories?post=9137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/tags?post=9137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}